Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
European Journal of Clinical Pharmacology|May 16, 2009
Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosisJadwiga Skretkowicz, Malgorzata Baranska, Mariola Rychlik-SychActa Poloniae Pharmaceutica|June 10, 2008
Oxidative phenotype status in related subjectsMariola Rychlik-Sych, Magdalena Łyczba, Jadwiga SkretkowiczPrzeglad Lekarski|July 7, 2012
[Clinical significance of pharmacogenetics in dermatological diseases]Mariola Rychlik-Sych, Małgorzata Barańska, Jadwiga SkritkowiczWiadomosci Lekarskie (Warsaw, Poland : 1960)|March 18, 2015
[Clinical significance of pharmacogenetics in psychiatry]Jadwiga Skrętkowicz, Małgorzata Barańska, Mariola Rychlik-SychActa Poloniae Pharmaceutica|December 5, 2008
Polymorphism of dextromethorphan oxidation in Polish populationJadwiga Skretkowicz, Anna Wojtczak, Mariola Rychlik-SychArchives of Medical Science : AMS|February 1, 2012
Genetic polymorphisms of CYP2D6 oxidation in patients with systemic lupus erythematosusJadwiga Skrętkowicz, Małgorzata Barańska, Anna Kaczorowska, et al.Pharmacological Reports : PR|January 16, 2008
CYP2D6 phenotyping with dextromethorphanAnna Wojtczak, Mariola Rychlik-Sych, Eliza Krochmalska-Ulacha, et al.Archives of Medical Science : AMS|October 23, 2024
Polymorphism rs662 (Q192R) of paraoxonase-1 and susceptibility to atherosclerosis of the coronary arteriesMalgorzata Baranska, Mariola Rychlik-Sych, Michal Dudarewicz, et al.Pharmacological Reports : PR|June 5, 2012
Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosisMałgorzata Barańska, Bożena Dziankowska-Bartkowiak, Elżbieta Waszczykowska, et al.Pharmacological Reports : PR|June 5, 2012
C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish populationMichał Dudarewicz, Małgorzata Barańska, Mariola Rychlik-Sych, et al.Pageof 2